Cansino Biologics Inc

6185-HK:Hong Kong Stock Exchange
*Data is delayed | HKD
Last | 2:13 PM CTT
263.80quote price arrow up+12.80 (+5.10%)
Volume
769,890
52 week range
59.00 - 285.80

...

Loading . . .

KEY STATS

  • Open252.00
  • Day High265.00
  • Day Low250.00
  • Prev Close251.00
  • 52 Week High285.80
  • 52 Week High Date05/21/20
  • 52 Week Low59.00
  • 52 Week Low Date01/30/20
  • Market Cap6,725.09M
  • Shares Out222.65M
  • 10 Day Average Volume1.87M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change322.08

RATIOS/PROFITABILITY

  • EPS (TTM)-0.94
  • P/E (TTM)-281.84
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Cansino Biologics Inc News

There is no recent news for this security.

Latest 6185-HK News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.
Xuefeng Yu
Chairman
Shou Bai Chao
Chief Operating Officer
Jing Wang
Chief Financial Officer
Address
Tianjin, TNJ
300457
China